Avanir Pharmaceuticals (AVNR)
|
2.81
-0.04 (-1.40%)
|
|
|
|
AVNR additional information
Market Data powered by QuoteMedia. Data delayed 15 minutes unless otherwise indicated. Filings and Fundamentals by Morningstar, Insiders by Vickers (USA) and SEDI(CDN), analyst ratings by Zacks.
AVNR Profile
•
Exchange
NASDAQ
•
Held by these Mutual Funds
T. Rowe Price Health Sciences
Fidelity Select Biotechnology
Vanguard Extended Market Idx
iShares Russell 2000 Growth Index
CREF Stock
DFA US Micro Cap I
Vanguard Instl Ttl Stk Mkt Idx InstlPlus
Bridgeway Ultra-Small Company Market
iShares Russell Microcap Index
VALIC Company I Health Sciences
Fidelity Select Biotechnology
Vanguard Extended Market Idx
iShares Russell 2000 Growth Index
CREF Stock
DFA US Micro Cap I
Vanguard Instl Ttl Stk Mkt Idx InstlPlus
Bridgeway Ultra-Small Company Market
iShares Russell Microcap Index
VALIC Company I Health Sciences
•
Competitors
•
Executives
Mr. Keith A. Katkin
Chief Exec. Officer
Pres Director and Member of Exec. Committee
Ms. Christine G. Ocampo CPA
Principal Financial Officer
Principal Accounting Officer VP of Fin. and Sec.
Dr. Joao Siffert M.D.
Sr. VP of R&D
Dr. Randall E. Kaye M.D.
Chief Medical Officer and Sr. VP
Mr. Gregory J. Flesher
Chief Bus. Officer and Sr. VP
Chief Exec. Officer
Pres Director and Member of Exec. Committee
Ms. Christine G. Ocampo CPA
Principal Financial Officer
Principal Accounting Officer VP of Fin. and Sec.
Dr. Joao Siffert M.D.
Sr. VP of R&D
Dr. Randall E. Kaye M.D.
Chief Medical Officer and Sr. VP
Mr. Gregory J. Flesher
Chief Bus. Officer and Sr. VP
•
Employee Count
188
Special Offers
Competitors
AVNR earnings
Date
Actual
Expected
Prev Yr Qtr
8/8/2012
-0.11
-0.11
-0.13
5/8/2012
-0.13
-0.12
-0.12
2/7/2012
-0.12
-0.13
-0.11
